Results 221 to 230 of about 142,867 (308)
Ferroptosis in biliary tract cancer: Molecular mechanisms and therapeutic applications (Review). [PDF]
Zou R, Dai Y, Yang S, Hu H, Li F, Liu F.
europepmc +1 more source
Role of glutathione and cysteine in acrylamide metabolism during in vitro and in vivo digestion
Abstract Background Acrylamide, a probable human carcinogen found in thermally processed potato products, is reactive towards amino and thiol compounds. This reactivity suggests acrylamide might react with them in the gastrointestinal tract resulting in mitigation of associated risk with acrylamide.
Burçe Ataç Mogol +11 more
wiley +1 more source
Impact of ERCC1 on the outcomes of chemotherapy in advanced biliary tract cancer. [PDF]
Sakamoto Y +24 more
europepmc +1 more source
Abstract BACKGROUND Hazelnuts and foods produced using hazelnuts are consumed with pleasure, but it is important to evaluate the waste generated during hazelnut processing and determine their usage methods. RESULTS This study was conducted to determine the changes in bioactive components, bioaccessibility and antidiabetic activity of nanoparticles ...
Mehmet Ali Temiz, Emine Okumus
wiley +1 more source
Adjuvant tislelizumab, lenvatinib, and capecitabine for resected biliary tract cancer: a prospective phase II trial. [PDF]
Feng Y +7 more
europepmc +1 more source
ABSTRACT Background and Objectives This study aimed to evaluate the ability of perioperative inflammatory markers to discriminate postoperative complications within 6 months in patients with ovarian cancer–related peritoneal metastasis undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Donmez Mustafa +6 more
wiley +1 more source
T-Cadherin in Biliary Tract Cancer Stroma, a Potent Pharmacological Target for Biliary Tract Carcinogenesis. [PDF]
Hanamatsu Y, Saigo C, Takeuchi T.
europepmc +1 more source
ABSTRACT This trial was to evaluate the efficacy and the safety of colchicine for the palliative treatment of patients with primary hepatic malignancy unable to receive curative treatment. Forty hepatocellular carcinoma (HCC) patients and two intrahepatic cholangiocarcinoma (ICC) patients signed the informed consents.
Zu‐Yau Lin +8 more
wiley +1 more source

